Analytics

Equity Analytics

On the record this week: what the Street published, what insiders filed, and what reports next.

Equity Analytics/BMRN

BMRN

BioMarin Pharmaceutical Inc.

Healthcare - US

BioMarin Pharmaceutical Inc. is a global biotechnology company specializing in the development and commercialization of innovative therapies for rare genetic diseases and serious medical conditions. Founded in 1997 and headquartered in San…

HQ: San Rafael, CA, United States of Americawww.biomarin.com

USD65.68+0.26%vs prev. close

Market snapshot

Price

USD65.68

Daily move

+0.26%

P/E

177.5

EPS TTM

0.37

Dividend yield

—

Beta

0.24

Market cap

12.7B

Price history

BMRN price

USD

VolumeLog scale

No price history available

Next earnings

No upcoming earnings report scheduled in the next 6 months.

Peer comparison

Company	Ticker	Industry	Mkt cap (USD bn)	P/E	Div yld	1W	1M	3M	6M	1Y	YTD
BioMarin Pharmaceutical	BMRN	Biotechnology	12.7	177.5	—	-1.3%	-6.5%	+17.4%	+12.3%	+17.5%	+10.5%

Subscribe to Equity Analytics to compare BMRN with its closest peers

Sector-matched peer set with side-by-side valuation, dividend and performance over every window.

View plans

Ask Ashenden

One question, one concise answer grounded in Ashenden research.

Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.